Motility Function Clinical Trial
— EMAPOfficial title:
Esophageal Manometry During Recovery From Anesthesia: Pilot Study
| NCT number | NCT02661386 |
| Other study ID # | 14-15466 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 2016 |
| Est. completion date | December 2021 |
1. An intact pharyngoesophageal reflex is essential to protect the upper airway from aspiration of either mouth contents or regurgitated gastric refluxate. This reflex is essential at protecting the airway in all patients. 2. In patients, while under general anesthesia, it is postulated that an identifiable upper esophageal sphincter and esophageal peristalsis are not present. 3. With the cessation of general anesthetics, accompanied by the reversal of nerve block, normal pharyngoesophageal peristaltic activity correlates with awakening the patient from anesthesia. This would be identified by the performance of esophageal manometry. 4. A return of normal verbally stimulated pharyngoesophageal swallowing sequence accurately identifies a safe time to remove endotracheal tubes and/or reverse anesthesia. This verbally stimulated swallowing sequence correlated precisely with the return of objective pharyngoesophageal function.
| Status | Recruiting |
| Enrollment | 10 |
| Est. completion date | December 2021 |
| Est. primary completion date | July 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility | Inclusion Criteria: - Patients between 18 and 70 years of age (ASA I or II). - Already scheduled for routine general anesthetic procedure requiring an endotracheal tube for anesthesia administration. - Scheduled abdominal surgical procedure including endoscopy, colonoscopy, ERCP, cholecystectomy, appendectomy, colectomy or small bowel resection. - Willing and able to give informed consent in either English or Spanish. Exclusion Criteria: - Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study. - Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. - Patients not meeting entry criteria above. - Refusal to give informed consent. - Coagulopathy (INR > 2 and/or platelet count < 100,000. - White Blood Cell count < 5,000/mm3 - Arrhythmia - Serum creatinine > 2 mg/dl - Prior known or suspected nasal obstruction. - Known or suspected Zenker's diverticulum of esophagus, esophageal stricture, head/neck radiation therapy, hereditary telangiectasis, esophageal varices, cirrhosis. - Anticoagulant usage such as heparin or Plavix |
| Country | Name | City | State |
|---|---|---|---|
| United States | Zuckerberg San Francisco General Hospital | San Francisco | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of California, San Francisco |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Total time of the return of normal pharyngoesophageal function | Our primary objective is to determine the timing of the return of normal pharyngoesophageal function upon withdrawal of general anesthesia. | During the last 15 minutes of general anesthesia use | |
| Secondary | Number of participants with normal pharyngoesophageal function. | Correlation of the return of normal pharyngoesophageal function with other markers generally used by Anesthesia staff to indicate a safe time for removal of endotracheal tubes. | During the last 15 minutes of general anesthesia use |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05574465 -
Esophageal Manometry During Recovery From Endotracheal Intubation
|
N/A |